Clinical and Translational Research (MS)
The Master of Science (M.S.) degree program in Clinical and Translational Research (MCTR) is administered by the Connecticut Convergence Institute for Translation in Regenerative Engineering at the University of Connecticut. The program, which stresses clinical research methods and a research practicum, is offered to individuals with a health-related terminal degree (for example, M.D., Ph.D., Pharm.D., D.D.S., or D.M.D.) to provide practical research training in preparation for independent research. Due to course sequencing, students are typically admitted for the Fall semester. All work must be completed within four years from the beginning of study, which is defined as the beginning date of the earliest course, wherever taken, listed on the approved Master’s Plan of Study. The three core courses in clinical and translational research are generally taken consecutively; therefore, the minimum timeframe to complete the program is 18 months. Students must submit a Plan of Study no later than the beginning of their final semester before degree completion. The MCTR program is a Plan B (non-thesis) program. Students are required to complete a final examination, which entails the oral defense of a grant application and a manuscript. Final examination materials (grant application and manuscript) must be submitted to the MCTR Administrative Office at least three weeks prior to the student’s final exam.